The Vanderbilt Patient-Reported Outcomes Measurement System has collected its millionth patient-reported outcome measure (PROM), or pre-appointment survey that patients complete about their health, making it one of the largest collections of such surveys in the United States.

Vanderbilt research shows that a liquid biopsy-based multicancer early detection (MCED) test could detect 12 types of cancers, including low DNA-shedding cancers and early-stage cancers.

MyCap is a secure, customizable mobile computing application (for smartphone or tablet) used to collect data from research participants on a remote basis. At Vanderbilt University Medical Center, where MyCap was created and launched in 2018, some 107 projects have used the app, and by 2021, research participants in 135 countries had installed the free app.

The American Association of Critical-Care Nurses (AACN) is presenting the research team of Brenda Pun, DNP, RN, FCCM and E. Wesley Ely, MD, MPH, with its AACN Pioneering Spirit Award.

Vanderbilt University Medical Center's Lea Davis, PhD, and longtime colleagues Ekaterina (Katya) Khramtsova, PhD, and Barbara Stranger, PhD, are among seven authors of a paper published May 11 in the journal Cell that outlines “best practices” for evaluating the impact of both sex and gender on human health.

Vanderbilt Diabetes Day, an annual event hosted by the now-named Vanderbilt Diabetes Research and Training Center (DRTC). The event spotlights the work of researchers, and this year also celebrated the 50-year anniversary of the DRTC.

Pretreatment of an animal model with a novel compound called PHAD reduced kidney injury, suggesting it may be a good candidate for preventing kidney injury in surgical patients.